Holen Sie sich die Stockscreener-App
15.25
2.07%
0.31
Handel nachbörslich:
15.27
0.02
+0.13%
Schlusskurs vom Vortag:
$14.94
Offen:
$14.93
24-Stunden-Volumen:
361.42K
Relative Volume:
0.65
Marktkapitalisierung:
$5.40B
Einnahmen:
$4.89B
Nettoeinkommen (Verlust:
$-263.00M
KGV:
-19.72
EPS:
-0.7734
Netto-Cashflow:
$-167.84M
1W Leistung:
-0.78%
1M Leistung:
+0.33%
6M Leistung:
+32.61%
1J Leistung:
-25.65%
1-Tages-Spanne:
$14.60
$15.29
1-Wochen-Bereich:
$14.60
$16.00
52-Wochen-Spanne:
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
Firmenname
Bausch Lomb Corp
Sektor
Telefon
908-541-5456
Adresse
520 APPLEWOOD CRESCENT, VAUGHAN
Vergleichen Sie BLCO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.25 | 5.29B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | Goldman | Neutral |
| 2025-05-02 | Bestätigt | H.C. Wainwright | Buy |
| 2025-03-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Eingeleitet | Raymond James | Outperform |
| 2024-05-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Eingeleitet | Stifel | Hold |
| 2023-10-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Eingeleitet | Needham | Hold |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-06-24 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-06 | Eingeleitet | Citigroup | Buy |
| 2022-05-31 | Eingeleitet | Deutsche Bank | Hold |
| 2022-05-31 | Eingeleitet | Goldman | Neutral |
| 2022-05-31 | Eingeleitet | Guggenheim | Buy |
| 2022-05-31 | Eingeleitet | JP Morgan | Neutral |
| 2022-05-31 | Eingeleitet | Jefferies | Buy |
| 2022-05-31 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-05-11 | Eingeleitet | Cowen | Outperform |
Alle ansehen
Bausch Lomb Corp Aktie (BLCO) Neueste Nachrichten
Bausch + Lomb (NYSE/TSX: BLCO) to hold Investor Day outlining 3-year plan and pipeline - Stock Titan
Is Bausch + Lomb Corporation stock safe for conservative investors2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
What margin trends mean for Bausch + Lomb Corporation stock2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com
Bausch + Lomb (NYSE:BLCO) Seems To Be Using A Lot Of Debt - 富途牛牛
What is the fair value estimate for Bausch + Lomb Corporation (S2L) stock in 2025Fed Meeting & Risk Managed Investment Entry Signals - newser.com
Q4 EPS Estimates for Bausch + Lomb Raised by HC Wainwright - MarketBeat
How strong is Bausch + Lomb Corporation stock revenue growthChart Signals & Stock Timing and Entry Methods - newser.com
Real time breakdown of Bausch + Lomb Corporation stock performance2025 Sector Review & Weekly High Conviction Ideas - newser.com
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Forecasting Bausch + Lomb Corporation price range with options dataOptions Play & Step-by-Step Trade Execution Guides - newser.com
Using data models to predict Bausch + Lomb Corporation stock movementJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Bausch + Lomb (BLCO) Net Losses Deepen 53.3% Annually Despite Turnaround Hopes - Sahm
Bausch + Lomb (NYSE:BLCO) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Bausch + Lomb's (BLCO) Outperform Rating Reaffirmed at Raymond James Financial - MarketBeat
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $16 to $17 - 富途牛牛
7 Analysts Have This To Say About Bausch & Lomb - Benzinga
Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $17 - 富途牛牛
Why Bausch + Lomb Corporation stock could see breakout soonWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com
Bausch & Lomb Corp (BLCO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
J.P. Morgan Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Cuts Target Price to $16 - 富途牛牛
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $13 to $17 - 富途牛牛
Bausch + Lomb Corporation (NYSE:BLCO) Q3 2025 Earnings Call Transcript - Insider Monkey
What Bausch + Lomb (BLCO)'s Strong Q3 Results and Pipeline Progress Mean For Shareholders - Sahm
BLCO Q3 Deep Dive: Pharmaceuticals and Pipeline Drive Growth, Margin Initiatives Take Shape - Yahoo! Finance Canada
Bausch + Lomb Reports Q3 2025 Financial Results - TipRanks
A Look at Bausch + Lomb’s (BLCO) Valuation After Q3 Earnings Beat and Upgraded 2025 Guidance - Yahoo Finance
Needham Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating - 富途牛牛
Bausch + Lomb Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch + Lomb Lifts Guidance After Beating Earnings Forecasts - Finimize
Bausch + Lomb (BLCO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Bausch + Lomb Higher in Pre-market as Q3 Adjusted Income, Revenue, Beat Forecasts - 富途牛牛
Bausch + Lomb Outpaces Expectations With Strong Q3 Results - Finimize
Bausch + Lomb (BLCO) Q3 Earnings Beat Estimates - Nasdaq
Short interest data insights for Bausch + Lomb Corporation2025 Earnings Impact & Community Driven Trade Alerts - newser.com
Bausch + Lomb Announces Third-Quarter 2025 Results - BioSpace
Bausch + Lomb (NYSE:BLCO) Reports Q3 In Line With Expectations, Stock Soars - Yahoo Finance
Bausch + Lomb tops third-quarter expectations as pharmaceuticals, vision care lead growth - Investing.com
Bausch + Lomb Q3 2025 Financial Results - TradingView
Bausch & Lomb Corp (TSX:BLCO) Q3 2025: Everything You Need To Kn - GuruFocus
Why Bausch + Lomb Corporation stock is upgraded to buy2025 Risk Factors & Weekly Setup with ROI Potential - newser.com
Bausch + Lomb (BLCO) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Full technical analysis of Bausch + Lomb Corporation stockJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Bausch + Lomb Corp expected to post earnings of 16 cents a shareEarnings Preview - TradingView
Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $16 - 富途牛牛
Applying big data sentiment scoring on Bausch + Lomb CorporationJuly 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com
Can Bausch + Lomb Corporation stock hit record highs again2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com
Will Bausch + Lomb Corporation stock benefit from Fed rate cutsJuly 2025 Momentum & Short-Term High Return Strategies - newser.com
Custom strategy builders for tracking Bausch + Lomb CorporationPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
Weiss Ratings Reiterates "Sell (D-)" Rating for Bausch + Lomb (NYSE:BLCO) - MarketBeat
Finanzdaten der Bausch Lomb Corp-Aktie (BLCO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):